factual
Moderna Sold Platform Access Rather Than Single Drugs
Moderna pitched itself as a platform for sending RNA into cells, not a single drug company, and used that to sign early deals with AstraZeneca and Alexion totaling about $300 million upfront, while keeping the rest of the platform for itself.
factualpending
Speaker
Jason KellyEvidence Quote
“they did the deal with AstraZeneca, it was just in one area, but they reserved all the rest of their platform for themselves.”
Created: 11/15/2026, 7:57:10 PM
Your notes
Loading notes...